GET THE APP

..

Human Genetics & Embryology

ISSN: 2161-0436

Open Access

Editorial - (2022) Volume 13, Issue 2

Michel Hollard*
*Correspondence: Michel Hollard, Department of Embryology, University of Bremen, Germany, Email:
Department of Embryology, University of Bremen, Germany

Received: 04-Mar-2022 Editor assigned: 05-Mar-2022, Pre QC No. hgec-22-65136; Reviewed: 17-Mar-2022, QC No. Q-65136; ; Revised: 21-Mar-2022, Manuscript No. R-65136; ; Published: 29-Jun-2022 , DOI: 10.37421/2161-0436.2022.13.173
Citation: Hollard, Michel. “Recent Advances in Our Understanding of Bacterial Morphogenesis.” Human Genet Embryol 13 (2022): 173.
Copyright: © 2022 Hollard M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Description

The duplication and segregation of genetic material are only a small part of cellular replication. To house newly generated chromosomes, a new cell surface must be formed, and the expanded cellular compartment must be divided to generate daughter cells capable of restarting the cycle. Since the first visualisation of cells, scientists have been captivated by morphogenetic processes. Even in relatively simple creatures like bacteria, however, the mechanisms driving growth, cell division, and cell shape maintenance are still being unravelled. The peptidoglycan (PG) sacculus, a netlike macromolecule that encases the cytoplasmic membrane to protect it from osmotic lysis, keeps bacterial cells in shape. The PG sacculus is the only other cellular component, aside from the nucleoid, that exists as a single molecule that must be faithfully replicated in each cell cycle [1].

The sacculus' growth and division are controlled from within the cell by dynamic cytoskeletal structures, which require both synthetic and hydrolytic enzymes. Despite the fact that many of the actors engaged in these morphogenetic processes have been identified, little is known about how they all work together to create the cell wall, and even less about how PG growth is coordinated with nucleoid replication and synthesis other cell envelope layers. The reviews in this issue emphasise recent breakthroughs in our knowledge of bacterial morphogenesis and how viruses co-opt or undermine it during their reproduction cycle. The United Nations has sparked significant progress. The creation and use of innovative methods and technologies, as well as the study of atypical model organisms. Genome-wide, high-throughput analysis new mutant phenotypes and genetic interactions have been discovered through screens variables that play a role in cell division and growth [2].

The cellular localisation and dynamics of cells have been disclosed using super-resolution and time-lapse fluorescence microscopy, as well a electron crytotomography hitherto unimaginable levels of surface assembly components and cytoskeletal proteins resolution. Finally, biochemical and genetic research were combined with the ever-increasing number of novel protein structures reveals how the body works. The cubicle is meticulously constructed. Old findings have given rise to some of the most fascinating new methods for investigating cell wall formation. Miguel de Pedro, for example, discovered in the early 1990s that Escherichia coli incorporates specific D-amino acids into its PG sacculus, such as Dmethionine, D-leucine, and D-tyrosine. He then devised the ingenious technique of D-cysteine labelling PG to track the sacculus' development through the cell cycle. To elongate, E. coli cells inject additional PG material along their lateral wall in diffuse areas, according to his research. This method of elongation is followed by a brief period of zonal elongation via highly localised insertion of new material at mid cell, which is most visible in cells with restricted septal PG production [3].

Cava review's focuses on the many ways of cell wall growth in rodshaped bacteria, ranging from E. coli through Caulobacter crescentus to other aproteobacteria. All of these species switch between elongation and division modes of cell wall production during the cell cycle. However, the percentage of the cell cycle devoted to the various modalities of elongation, as well as the process of cell elongation itself, differs between species. Both E. coli and C. crescentus insert new PG material along their cell length in a dispersed manner of development driven by the actin-like cytoskeletal protein MreB, as detailed by Cava et al. The time of the transition from mid cell to zonal mode of elongation is where they differ. In C. crescentus, this zonal phase of growth accounts for a large portion of total elongation, although it barely contributes to elongation in E. coli. Interestingly, additional a-proteobacteria members, such as MreB-independent elongation of Agrobacterium tumefaciens involves growth from the cell pole. These unique growth pathways can now be easily identified.

The fluorescently labelled D-amino acids were used to visualise the process as previously stated The current focus of research is on figuring out how the numerous rod-shaped cells position and interact how do they control the elongation of their cell walls, and how do they do it? Elongation is coordinated with other main cell cycle events. MreB and the divisome factor FtsA are both actin-like proteins that form polymers that connect with the membrane via amphipathic helical domains, according to structural and biochemical investigations. As noted in the review, these two proteins are likely performing similar functions inside their separate complexes, and the two machineries may control PG biogenesis in a similar manner. In order for the divisome to favour a constrictive mode of growth rather than elongation, FtsZ and numerous other variables must be added to the equation [4,5].

Acknowledgement

We thank the anonymous reviewers for their constructive criticisms of the manuscript. The support from ROMA (Research Optimization and recovery in the Manufacturing industry), of the Research Council of Norway is highly appreciated by the authors.

Conflict of Interest

The Author declares there is no conflict of interest associated with this manuscript.

References

  1. Canzler, Sebastian, Jana Schor, Wibke Busch, and Kristin Schubert. “Prospects and challenges of multi-omics data integration in toxicology.” Human Genet Embryol 13 (2022): 371–388.
  2. Google Scholar, Crossref

  3. Wilmes, Anja , Chris Bielow , Christina Ranninger , and  Patricia Bellwon. “Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics.” Human Genet Embryol 13 (2022) 117-127.
  4. Google Scholar, Crossref, Indexed at

  5. Seeger, Bettina, Almut Mentz, Constanze Knebel, and Flavia Schmidt. “Assessment of mixture toxicity of (tri)azoles and their hepatotoxic effects in vitro by means of omics technologiesHuman Genet Embryol 13 (2022): 2321–2333.
  6. Google Scholar, Crossref, Indexed at

  7. Zhi, Hu Zhang, Hongzhan Huang, Anatoly Dritschilo, and Anton Wellstein. “Omics Data Are Particularly Useful For The Identification of Molecular Modes of Action or Toxic PathwaysHuman Genet Embryol 13 (2022): 547–571.
  8. Google Scholar, Crossref, Indexed at

  9. Brockmeier, K .Erica., Geoff HodgesLami, Emma Butler, and Markus Hecker. “The Role of Omics in the  Application of Adverse Outcome Pathways for Chemical Risk Assessment.” Human Genet Embryol 13 (2022):     252-262.
  10. Google Scholar, Crossref, Indexed at

Google Scholar citation report
Citations: 309

Human Genetics & Embryology received 309 citations as per Google Scholar report

Human Genetics & Embryology peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward